作者：
Tomblyn,M. [1]
;
Chen,M. [2]
;
Kukreja,M. [3]
;
Aljurf,M.D. [4]
;
AlMohareb,F. [5]
;
Bolwell,B.J. [6]
;
Cahn,J.-Y. [7]
;
Carabasi,M.H. [8]
;
Gale,R.P. [9]
;
Gress,R.E. [10]
;
Gupta,V. [11]
;
Hale,G.A. [12]
;
Ljungman,P. [13]
;
Maziarz,R.T. [14]
;
Storek,J. [15]
;
Wingard,J.R. [16]
;
Young,J.-A.H. ;
Horowitz,M.M. ;
Ballen,K.K.
作者单位：
Bone Marrow Transplant, Massachusetts General Hospital, Boston, MA, United States
[1]
Bone Marrow Transplant, Cleveland Clinic Foundation, Cleveland, OH, United States
[2]
Hematology/Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA, United States
[3]
Adult Stem Cell Transplantation, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi
[4]
Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
[5]
Clinical Trials Office, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United
[6]
Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Karolinska
[7]
Bone Marrow Transplant, Center for Hematologic Malignancies, Oregon Health and Science University
[8]
Service d'Hematologie, H?pital A. Michallon - CHU de Grenoble, Grenoble, France
[9]
Experimental Transplantation and Immunology, National Institutes of Health, Bethesda, MD, United
[10]
Blood and Marrow Transplant Program, All Children's Hospital, St. Petersburg, FL, United States
[11]
Hematology and Medical Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Canada
[12]
Bone Marrow Transplant, Medical Hematology/Oncology, Shands Hospital, University of Florida
[13]
Clinical Research, Celgene Corporation, Summit, NJ, United States
[14]
Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin
[15]
Bone Marrow Transplant Program, Tom Baker Cancer Centre, University of Calgary, AB, Canada
[16]
发布时间
2013-11-20
换一批
